Tango Therapeutics, Inc. · NASDAQ:TNGX
Newcomb Jessica sold 7,031 Tango Therapeutics, Inc. shares (Form 4)
Traded Nov 2, 2026 · Filed Nov 4, 2026
On Nov 2, 2026, Newcomb Jessica (Principal Accounting Officer) sold 7,031 Tango Therapeutics, Inc. shares at an average US$22.42 for US$158K under a trading plan, leaving 52,090 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 7,031 shares
- Price
- US$22.42 average (US$22.28 to US$22.98)
- Value
- US$158K
- Holding after
- 52,090 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Principal Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | Sale | 5,571 | US$22.28 | 53,550 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,460 | US$22.98 | 52,090 | Direct |
Source
Download original · View original at SEC
Related
- Tango Therapeutics, Inc.
- Newcomb Jessica
- Tango Therapeutics, Inc. shareholders
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Ketchum John B · Nov 19, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Nov 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Nov 16, 2026
- Form 4 · Crystal Adam · Nov 13, 2026
- Schedule 13G/A · FMR LLC · Nov 6, 2026